Therapeutic potential of endothelin receptor antagonists in diabetes (Q34090982)

30 July 2017

1 reference

title

Therapeutic potential of endothelin receptor antagonists in diabetes (English)

1 reference

ORCID Public Data File 2021

30 July 2017

1 reference

author name string

Chakrabarti S

1

1 reference

30 July 2017

Cukiernik M

2

1 reference

30 July 2017

Mukherjee S

3

1 reference

30 July 2017

Chen S

4

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 December 2000

1 reference

Expert Opinion on Investigational Drugs

30 July 2017

published in

1 reference

30 July 2017

volume

9

1 reference

30 July 2017

issue

12

1 reference

30 July 2017

page(s)

2873-2888

1 reference

The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2873

The cellular and molecular mechanisms of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2873

Endothelin-1 and endothelin receptor antagonists in cardiovascular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2873

Pathophysiology of endothelin in the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2873

Heparin has an inhibitory effect on endothelin-1 synthesis and release by endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2873

Molecular characterization of endothelin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2873

Endothelin antagonism with bosentan: a review of potential applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2873

Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2873

Discovery and synthesis of (S)-3-[2-(3,4-dimethoxyphenyl)ethoxy]-2- (4,6-dimethylpyrimidin-2-yloxy)-3,3-diphenylpropionic acid (LU 302872), a novel orally active mixed ET(A)/ET(B) receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2873

Comparison of PD 145065 and Ro 46-2005 as antagonists of contractions of guinea-pig airways induced by endothelin-1 or IRL 1620.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2873

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2873

Lessons from the Diabetes Control and Complications Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2873

Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2873

Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2873

Prevention of hemodynamic and vascular albumin filtration changes in diabetic rats by aldose reductase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2873

Treatment with aldose reductase inhibitor or with myo-inositol arrests deterioration of the electroretinogram of diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2873

Diabetic nephropathy in type 1 (insulin-dependent) diabetes: An epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2873

Diabetes mellitus and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2873

Cardiac consequences of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2873

Protein kinase C activation and the development of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2873

Abnormalities of retinal metabolism in diabetes or experimental galactosemia. IV. Antioxidant defense system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2873

The oxidation of oxyhaemoglobin by glyceraldehyde and other simple monosaccharides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2873

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2873

Regulation of protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2873

Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2873

Increased endothelial albumin permeability mediated by protein kinase C activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2873

Enhanced expression of inducible nitric oxide synthase in murine macrophages and glomerular mesangial cells by elevated glucose levels: possible mediation via protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2873

Characterization of the advanced glycation end-product receptor complex in human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2873

The role of oxidative stress and NF-kappaB activation in late diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2873

Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2873

BCL-2 expression or antioxidants prevent hyperglycemia-induced formation of intracellular advanced glycation endproducts in bovine endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2873

Endothelin: emerging role in diabetic vascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2873

Insulin stimulates production and secretion of endothelin from bovine endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2873

Targeted overexpression of protein kinase C beta2 isoform in myocardium causes cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2873

Vasoactive peptides modulate vascular endothelial cell growth factor production and endothelial cell proliferation and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2873

Endothelin 1 transcription is controlled by nuclear factor-kappaB in AGE-stimulated cultured endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2873

Time-dependent up-regulation of endothelin-A receptors and down-regulation of endothelin-B receptors and nitric oxide synthase binding sites in the renal medulla of a rabbit model of partial bladder outlet obstruction: potential clinical relevance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2873

Regulation of endothelin-1 mRNA by angiotensin II in rat heart endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2873

Positive chronotropic effects of endothelin, a novel endothelium-derived vasoconstrictor peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2873

Experimental diabetic neuropathy: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2873

1,2-diacylglycerol content and its arachidonyl-containing molecular species are reduced in sciatic nerve from streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2873

Effects of endothelin receptor antagonism with bosentan on peripheral nerve function in experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2873

Differential regulation of nitric oxide synthase-II mRNA by growth factors in rat, bovine, and human retinal pigmented epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2873

Endothelin receptor antagonism in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2873

Pathophysiology of Progressive Nephropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.12.2873

10.1517/13543784.9.12.2873

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference